Loss of PLK2 induces acquired resistance to temozolomide in GBM via activation of notch signaling

BACKGROUND: Glioblastoma (GBM) is a lethal type of primary brain tumor with a median survival less than 15 months. Despite the recent improvements of comprehensive strategies, the outcomes for GBM patients remain dismal. Accumulating evidence indicates that rapid acquired chemoresistance is the majo...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Exp Clin Cancer Res
Asıl Yazarlar: Alafate, Wahafu, Xu, Dongze, Wu, Wei, Xiang, Jianyang, Ma, Xudong, Xie, Wanfu, Bai, Xiaobin, Wang, Maode, Wang, Jia
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2020
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7657349/
https://ncbi.nlm.nih.gov/pubmed/33176854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-020-01750-4
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller